Special Issue "Cisplatin in Cancer Therapy: Molecular Mechanisms of Action 3.0".
Valentina GandinJames D HoescheleNicola MargiottaPublished in: International journal of molecular sciences (2023)
The year 2023 marks the 45th year since FDA approval of cisplatin as an anticancer drug, and, at present, it is widely used against a spectrum of human tumors, including early-stage ovarian cancer, non-small cell lung cancer (typically developed by smokers), head and neck, and advanced bladder cancer [...].